Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Losee L Ling

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Targets|July 30, 2003
Microbial pathogen genomes - new strategies for identifying therapeutic and vaccine targetsTimothy Opperman, Losee L Ling, Donald T Moir
The Journal of Antibiotics|July 22, 2010
Uncultured microorganisms as a source of secondary metabolitesKim Lewis, Slava Epstein, Anthony D'Onofrio, et al.
Nature Protocols|March 14, 2018
In situ cultivation of previously uncultivable microorganisms using the ichipBrittany Berdy, Amy L Spoering, Losee L Ling, et al.
International Journal of Biological Macromolecules|September 8, 2023
Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide LassomycinManas K Jagdev, Dharma R Tompa, Losee L Ling, et al.
Journal of Natural Products|May 20, 2009
Isofuranonaphthoquinone produced by an Actinoplanes isolateQibo Zhang, Aaron J Peoples, Mithra T Rothfeder, et al.
The Journal of Antibiotics|September 9, 2008
Neocitreamicins I and II, novel antibiotics with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant EnterococciAaron J Peoples, Qibo Zhang, William P Millett, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductaseLosee L Ling, Jun Xian, Syed Ali, et al.
The Journal of Organic Chemistry|January 19, 2023
Synthesis and Stereochemical Determination of the Peptide Antibiotic Novo29Maj Krumberger, Xingyue Li, Adam G Kreutzer, et al.
Pathogens (Basel, Switzerland)|September 25, 2020
Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit ModelWilliam S Lawrence, Jennifer E Peel, Satheesh K Sivasubramani, et al.
ACS Infectious Diseases|February 27, 2025
Teixobactin: A Resistance-Evading Antibiotic for Treating AnthraxWilliam S Lawrence, Jennifer E Peel, Rosan de Winter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|July 30, 2003
Microbial pathogen genomes - new strategies for identifying therapeutic and vaccine targetsTimothy Opperman, Losee L Ling, Donald T Moir
The Journal of Antibiotics|July 22, 2010
Uncultured microorganisms as a source of secondary metabolitesKim Lewis, Slava Epstein, Anthony D'Onofrio, et al.
Nature Protocols|March 14, 2018
In situ cultivation of previously uncultivable microorganisms using the ichipBrittany Berdy, Amy L Spoering, Losee L Ling, et al.
International Journal of Biological Macromolecules|September 8, 2023
Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide LassomycinManas K Jagdev, Dharma R Tompa, Losee L Ling, et al.
Journal of Natural Products|May 20, 2009
Isofuranonaphthoquinone produced by an Actinoplanes isolateQibo Zhang, Aaron J Peoples, Mithra T Rothfeder, et al.
The Journal of Antibiotics|September 9, 2008
Neocitreamicins I and II, novel antibiotics with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant EnterococciAaron J Peoples, Qibo Zhang, William P Millett, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductaseLosee L Ling, Jun Xian, Syed Ali, et al.
The Journal of Organic Chemistry|January 19, 2023
Synthesis and Stereochemical Determination of the Peptide Antibiotic Novo29Maj Krumberger, Xingyue Li, Adam G Kreutzer, et al.
Pathogens (Basel, Switzerland)|September 25, 2020
Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit ModelWilliam S Lawrence, Jennifer E Peel, Satheesh K Sivasubramani, et al.
ACS Infectious Diseases|February 27, 2025
Teixobactin: A Resistance-Evading Antibiotic for Treating AnthraxWilliam S Lawrence, Jennifer E Peel, Rosan de Winter, et al.
Pageof 2